NCT02001415

Brief Summary

The purpose of this study is to determine the efficacy of different lens treatments (normal spectacle lens, ortho-K, \& Myovision) on myopia control in Chinese adolescent patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

November 23, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 4, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

April 25, 2016

Status Verified

April 1, 2016

Enrollment Period

2.8 years

First QC Date

November 23, 2013

Last Update Submit

April 21, 2016

Conditions

Keywords

Progressive MyopiaContact LensesSpectacles

Outcome Measures

Primary Outcomes (1)

  • Change of Ocular Axial Length

    Ocular axial length (AL), which increases with age, will be measured 3 times by an IOLMaster. The first AL examination was considered as the baseline data, and will be repeated 6 and 12 months later.

    Baseline, 6 months, 12 months

Secondary Outcomes (1)

  • Change of Spherical Equivalent Refraction

    Baseline, 6 months, 12 months

Study Arms (3)

Spectacles

ACTIVE COMPARATOR

Spectacles are the most common lens treatment to correct myopia. This arm is set to be as a control group for the other two arms. Myopia patients who enter in this group will wear a normal pair of glasses after the baseline examinations (axial length, refraction...).

Other: Spectacles

Myovison

ACTIVE COMPARATOR

Myovision is a kind of specially designed, commercially available spectacle lenses that could control the peripheral refraction of myopia patients. Latest studies have changed the understanding of myopia--correcting both central and peripheral vision during lens treatment is indicating to be an effective way of slowing down eye growth. Patients who entered this group will wear a pair of Myovision after baseline examinations.

Other: Myovision

Ortho-K

ACTIVE COMPARATOR

Orthokeratology has recently been reported as an effective way to control eye growth for myopia adolescents. Patents who enter this group will wear ortho-K lenses during sleep after baseline examinations.

Other: Orthokeratology

Interventions

Normal spectacle lenses were used to correct myopia as the control group.

Spectacles

Myovision is a kind of specially designed spectacle glasses that could control the peripheral refraction of myopia patients. It is commercially available.

Myovison

Orthokeratology lenses.

Ortho-K

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Adolescent myopia patients
  • Myopic refraction between -1.00D and -4.50D
  • Astigmatism equal or less than -1.50D
  • Normal break up time of tear film (BUT \> 10s)

You may not qualify if:

  • Existence of any ocular diseases except ametropia
  • Hyperopia
  • Severe dry eye

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmology Department of Peking University People's Hospital

Beijing, 100044, China

RECRUITING

MeSH Terms

Conditions

Myopia, Degenerative

Interventions

Eyeglasses

Condition Hierarchy (Ancestors)

MyopiaRefractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Study Officials

  • Kai Wang, Dr.

    Peking University People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xi Rong Wu, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2013

First Posted

December 4, 2013

Study Start

November 1, 2013

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

April 25, 2016

Record last verified: 2016-04

Locations